Skip to content
10-Q

Quarterly Report

Bio Essence Corp BIOE

0001213900-26-057529

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 15, 2026 46.81M sh
Stock Issued Q1 2026 · Mar 31, 2026 8.8M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$411.97K
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$26.07K
Long Term Debt Q1 2026 · Mar 31, 2026 $57.16K
Stockholders Equity Q1 2026 · Mar 31, 2026 −$1.43M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$2.07M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$3.17M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$2.97M
Current Liabilities Q1 2026 · Mar 31, 2026 $2.16M
Current Liabilities Q1 2026 · Dec 31, 2025 $2.44M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.22M
Total Liabilities Q1 2026 · Dec 31, 2025 $2.5M
Current Assets Q1 2026 · Mar 31, 2026 $788.99K
Current Assets Q1 2026 · Dec 31, 2025 $422.38K
Total Assets Q1 2026 · Mar 31, 2026 $789.03K
Total Assets Q1 2026 · Dec 31, 2025 $422.47K
Sga Expense Q1 2026 · Mar 31, 2026 $102.88K
Sga Expense Q1 2026 · Mar 31, 2025 $225.14K
Net Income Q1 2026 · Mar 31, 2026 $205.37K
Net Income Q1 2026 · Mar 31, 2025 −$205.75K
Operating Income Q1 2026 · Mar 31, 2026 $215.8K
Operating Income Q1 2026 · Mar 31, 2025 −$205.09K
Gross Profit Q1 2026 · Mar 31, 2026 $319.35K
Gross Profit Q1 2026 · Mar 31, 2025 $20.59K
Cost Of Revenue Q1 2026 · Mar 31, 2026 $181.18K
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.6K
Revenue Q1 2026 · Mar 31, 2026 $500.54K
Revenue Q1 2026 · Mar 31, 2025 $22.19K